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PS166.
ABO Blood Type is not Associated with Outcome after
Vascular Surgery
Koen M. van de Luijtgaarden, Erik J. Bakker, Sanne E.
Hoeks, Michiel T. Voute, Yvette R. van Gestel, Hence J.
Verhagen, Don Poldermans. Vascular Surgery, Erasmus
MC, Rotterdam, Netherlands
Objectives: Non-O blood types are associated with
higher levels of von Willebrand factor and factor VIII
and with increased risk of coronary, cerebral and periph-
eral arterial disease and venous thromboembolism. We
hypothesize that non-O blood type is a predictor of
long-term mortality after vascular surgery, although this
effect might be diminished by aspirin and/or Vitamin K
Antagonist use.
Methods: In 3255 major vascular surgery patients,
baseline characteristics, ABO blood type and follow-up
(mean 5 years) were obtained. The primary endpoint was
all-cause mortality, the secondary endpoint was Major Ad-
verse Cardiac Event (MACE). Multivariate analyses, cor-
recting for gender, medical history, left ventricular dysfunc-
tion and smoking, were used to evaluate the impact of ABO
blood type on mortality.
Results: Cardiovascular risk factors, medication and
type of surgery were well balanced between groups. All
patients were on chronic ASA/VKA therapy. Within 30 (ays after surgery, 3.4% of non-O and 3.6% of O patients
uffered MACE (OR 0.94; 95%CI 0.65-1.37). In a multi-
ariate model, O blood type was not associated with in-
reased mortality during long-term follow-up (HR 0.98;
5%CI 0.89-1.09).
Conclusions:Although associated with atherothrombo-
is and increased mortality in CAD, non-O blood type is not
ssociated with either short or long-termmortality in vascular
urgery patients. This discrepancy might be explained by the
igh rate of ASA/VKA use in our population.
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o Ethnic Differences and TASC Distribution Affect
he Incidence of Lower Extremity Amputation?
icholas J. Gargiulo1, David J. O’Connor2, William D.
uggs1, Larry A. Scher1, Omer Riaz1, Ashish Raju1, Yana
tkin1, Evan C. Lipsitz1. 1Department of Cardiovascular and
horacic Surgery, Albert Einstein College of Medicine and
ontefiore Medical Center, New York, NY; 2Mount Sinai
chool of Medicine, New York, NY
Objectives: There has been recent interest in ethnic
ifferences with a wide variety of disease entities. This
tudy was initiated to better determine what if any factors
ffected a diverse ethnic population afflicted with CLI.
Methods: We reviewed all patients presenting with
LI from January 1, 2007 to December 31, 2007. All
atients underwent conventional arteriography and if pos-
ible an endovascular, open or hybrid procedure for suc-
essful limb salvage. Multivariate logistic regression was
hen used to determine any association between ethnic
ackground and Rutherford Class, co-morbid conditions,
ransAtlantic InterSociety Consensus II (TASC II) classi-
cation, runoff score, types of intervention (open, endovas-
ular or hybrid), prior and repeat procedures, mortality and
ne-year amputation free survival (outcome).
Results: One hundred and forty eight patients pre-
ented with primary, secondary or tertiary CLI over this
ne year period. Of these, 58 (40% ) were Black,
7 (40%) were Latino and 28 (20%) were White. There
as no difference in clinical presentation among the
hree races (P 0.02). All groups had similar rates of
ASC II D iliac disease, however Blacks had a higher
revalence of TASC II D femoropopliteal disease
P0.02). Latinos and Caucasians had a higher preva-
